Epidermal growth factor receptor in asthma: A promising therapeutic target?

Activation of the epidermal growth factor receptor (EGFR) pathway is involved in the pathogenesis of asthma. Although decades of intensive research have focused on the role of EGFR in asthma, the specific mechanisms and pathways of EGFR signaling remain unclear. Various reports have indicated that inhibition of EGFR improves the pathological features in asthma models. However, extending these experimental findings to clinical applications is difficult. Several measures can be adopted to promote clinical application of EGFR inhibitors. This review focuses on the role of EGFR in the pathogenesis of asthma and the development of a potentially novel therapeutic target for asthma. Copyright © 2023 Elsevier Ltd. All rights reserved.

Citation

Ye Liu, Pengfei Li, Tianci Jiang, Yue Li, Yu Wang, Zhe Cheng. Epidermal growth factor receptor in asthma: A promising therapeutic target? Respiratory medicine. 2023 Feb;207:107117

Mesh Tags

Substances

PMID: 36626942

search → result